PriceTargets.com logo

Uniphar - UPR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: GBX 427.50
  • Forecasted Upside: 31.94%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 324 As of 12/5/2025 04:24 AM ET
▲ +3 (0.93%)

This chart shows the closing price for UPR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Uniphar Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UPR

Analyst Price Target is GBX 427.50
▲ +31.94% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Uniphar in the last 3 months. The average price target is GBX 427.50, with a high forecast of GBX 480 and a low forecast of GBX 375. The average price target represents a 31.94% upside from the last price of GBX 324.

This chart shows the closing price for UPR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 contributing investment analysts is to moderate buy stock in Uniphar. This rating has held steady since July 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/9/2025Royal Bank Of CanadaBoost TargetOutperformGBX 470 ➝ GBX 480
7/30/2025Deutsche Bank AktiengesellschaftReiterated RatingHoldGBX 375
5/29/2025Shore CapitalReiterated RatingBuy
2/25/2025Shore CapitalReiterated RatingBuy
1/28/2025Shore CapitalReiterated RatingBuy
9/4/2024Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 310
3/22/2023Shore CapitalReiterated RatingBuy
8/2/2021Shore CapitalReiterated RatingBuy
7/20/2021Shore CapitalReiterated RatingBuy
5/12/2021Shore CapitalReiterated RatingBuy
3/2/2021Shore CapitalReiterated RatingBuy
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Uniphar logo
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Read More

Today's Range

Now: GBX 324
Low: 321
High: 324

50 Day Range

MA: GBX 333.45
Low: 318
High: 350

52 Week Range

Now: GBX 324
Low: 163
High: 368

Volume

6,082 shs

Average Volume

44,985 shs

Market Capitalization

£841.02 million

P/E Ratio

13.22

Dividend Yield

0.52%

Beta

0.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Uniphar?

The following Wall Street analysts have issued research reports on Uniphar in the last twelve months: Deutsche Bank Aktiengesellschaft, Royal Bank Of Canada, and Shore Capital.
View the latest analyst ratings for UPR.

What is the current price target for Uniphar?

0 Wall Street analysts have set twelve-month price targets for Uniphar in the last year. Their average twelve-month price target is GBX 427.50, suggesting a possible upside of 31.9%. Royal Bank Of Canada has the highest price target set, predicting UPR will reach GBX 480 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of GBX 375 for Uniphar in the next year.
View the latest price targets for UPR.

What is the current consensus analyst rating for Uniphar?

Uniphar currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for UPR.

What other companies compete with Uniphar?

Other companies that are similar to Uniphar include UDG Healthcare, BTG, Abcam, Indivior and HUTCHMED. Learn More about companies similar to Uniphar.

How do I contact Uniphar's investor relations team?

Uniphar's physical mailing address is 4045 Kingswood Road, Citywest Business Park, Dublin D24 V06K, Ireland. The company's listed phone number is 353 1 428 7777. The official website for Uniphar is www.uniphar.ie. Learn More about contacing Uniphar investor relations.